EVALUATION OF ADRENAL MASSES WITH GADOLINIUM ENHANCEMENT AND FAT-SUPPRESSED MR IMAGING

被引：43

作者：

SEMELKA, RC

SHOENUT, JP

LAWRENCE, PH

GREENBERG, HM

MAYCHER, B

MADDEN, TP

KROEKER, MA

机构：

[1] Department of Radiology, St Boniface General Hospital MRI Facility and the University of Manitoba, Winnipeg, Manitoba

来源：

JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING | 1993年 / 3卷 / 02期

关键词：

ADRENAL GLAND; MR; NEOPLASMS; COMPARATIVE STUDIES; CONTRAST ENHANCEMENT; FAT SUPPRESSION; MYELOLIPOMA;

D O I：

10.1002/jmri.1880030208

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

A study was undertaken to determine the ability to characterize benign and malignant masses with unenhanced and contrast material-enhanced fast low-angle shot and fat-suppressed spin-echo magnetic resonance (MR) imaging. Thirty patients with adrenal masses detected at computed tomography (CT) underwent MR imaging within 14 days after CT. CT and MR images were interpreted in a prospective, blinded fashion. Sixteen patients had 20 benign adrenal masses, and 14 patients had 18 malignant masses. Quantitative measurements included percentage of contrast enhancement on immediate postcontrast dynamic images and periphery - center signal-to-noise ratio (S/N) on gadolinium-enhanced fat-suppressed images. Qualitative evaluation included determination of the regularity of lesion margins, homogeneity of signal intensity, and local extension. MR imaging depicted all adrenal masses discovered at CT examinations. Lesions ranged in diameter from 1 to 15 (mean, 4.4) cm. No significant difference was observed in percentage of contrast enhancement between benign (90.5% +/-59.0 [standard deviation]) and malignant (110.5% +/- 116.4) masses. A difference was observed between periphery - center S/N for benign (-.05 +/- 1.5) and malignant (7.7 +/- 9.8) masses; overlap between the two, however, occurred. Qualitative evaluation allowed correct characterization of 32 of 38 masses, comparing favorably with CT, which allowed characterization of 30 lesions.

引用

页码：337 / 343

页数：7

共 21 条

[1]

Reinig JW, Doppman JL, Dwyer AJ, Johnson AR, Knop RH, Adrenal masses differentiated by MR, Radiology, 158, pp. 81-84, (1986)

[2]

Reinig JW, Doppman JL, Dwyer AJ, Frank J, MRI of indeterminate adrenal masses, AJR, 147, pp. 493-496, (1986)

[3]

Chang A, Glazer HS, Lee JKT, Ling D, Heiken JP, Adrenal gland: MR imaging, Radiology, 163, pp. 123-128, (1987)

[4]

Baker ME, Blinder R, Spritzer C, Leight GS, Herfkens RJ, Dunnick NR, MR evaluation of adrenal masses at 1.5T, AJR, 153, pp. 307-312, (1989)

[5]

Kier R, McCarthy S, MR characterization of adrenal masses: field strength and pulse sequence considerations, Radiology, 171, pp. 671-674, (1989)

[6]

Debatin JF, Spritzer CE, Dunnick NR, Castleman disease of the adrenal gland: MR imaging features, AJR, 157, pp. 781-783, (1991)

[7]

Krestin GP, Steinbrich W, Friedmann G, Adrenal masses: evaluation with fast gradient‐echo MR imaging and Gd‐DTPA‐enhanced dynamic studies, Radiology, 171, pp. 675-680, (1989)

[8]

Krestin GP, Friedmann G, Fischbach R, Neufang KFR, Allolio B, Evaluation of adrenal masses in oncologic patients: dynamic contrast‐enhanced MR vs CT, J Comput Assist Tomogr, 15, pp. 104-110, (1991)

[9]

Berland LL, Koslin DB, Kenney PJ, Stanley RJ, Lee JY, Differentiation between small benign and malignant adrenal masses with dynamic incremental CT, AJR, 151, pp. 95-101, (1988)

[10]

Semelka RC, Chew W, Hricak H, Tomei E, Higgins CB, Fat saturation MR imaging of the abdomen, AJR, 155, pp. 1111-1116, (1990)

← 1 2 3 →